ALC vs. DOCS: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ALC and DOCS, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Overview
ALC’s market capitalization of 43.42 billion USD is substantially larger than DOCS’s 11.59 billion USD, indicating a significant difference in their market valuations.
DOCS carries a higher beta at 1.32, indicating it’s more sensitive to market moves, while ALC (beta: 0.70) exhibits greater stability.
| Symbol | ALC | DOCS |
|---|---|---|
| Company Name | Alcon Inc. | Doximity, Inc. |
| Country | CH | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Instruments & Supplies | Medical - Healthcare Information Services |
| CEO | David J. Endicott | Jeffrey A. Tangney |
| Price | 87.78 USD | 61.69 USD |
| Market Cap | 43.42 billion USD | 11.59 billion USD |
| Beta | 0.70 | 1.32 |
| Exchange | NYSE | NYSE |
| IPO Date | April 9, 2019 | June 24, 2021 |
| ADR | No | No |
Historical Performance
This chart compares the performance of ALC and DOCS by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period.
Data is adjusted for dividends and splits.
Profitability
Return on Equity
ALC
6.95%
Medical - Instruments & Supplies Industry
- Max
- 26.65%
- Q3
- 13.00%
- Median
- 1.08%
- Q1
- -8.11%
- Min
- -38.20%
ALC’s Return on Equity of 6.95% is on par with the norm for the Medical - Instruments & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.
DOCS
22.38%
Medical - Healthcare Information Services Industry
- Max
- 25.87%
- Q3
- 8.12%
- Median
- 2.99%
- Q1
- -18.32%
- Min
- -48.18%
In the upper quartile for the Medical - Healthcare Information Services industry, DOCS’s Return on Equity of 22.38% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Return on Invested Capital
ALC
4.39%
Medical - Instruments & Supplies Industry
- Max
- 20.14%
- Q3
- 7.36%
- Median
- 1.97%
- Q1
- -6.22%
- Min
- -20.00%
ALC’s Return on Invested Capital of 4.39% is in line with the norm for the Medical - Instruments & Supplies industry, reflecting a standard level of efficiency in generating profits from its capital base.
DOCS
17.37%
Medical - Healthcare Information Services Industry
- Max
- 26.81%
- Q3
- 8.81%
- Median
- 2.09%
- Q1
- -11.56%
- Min
- -32.60%
In the upper quartile for the Medical - Healthcare Information Services industry, DOCS’s Return on Invested Capital of 17.37% signifies a highly effective use of its capital to generate profits when compared to its peers.
Net Profit Margin
ALC
11.27%
Medical - Instruments & Supplies Industry
- Max
- 28.95%
- Q3
- 11.24%
- Median
- -2.83%
- Q1
- -12.85%
- Min
- -26.41%
A Net Profit Margin of 11.27% places ALC in the upper quartile for the Medical - Instruments & Supplies industry, signifying strong profitability and more effective cost management than most of its peers.
DOCS
39.13%
Medical - Healthcare Information Services Industry
- Max
- 39.13%
- Q3
- 9.34%
- Median
- 1.37%
- Q1
- -15.05%
- Min
- -39.66%
A Net Profit Margin of 39.13% places DOCS in the upper quartile for the Medical - Healthcare Information Services industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin
ALC
15.22%
Medical - Instruments & Supplies Industry
- Max
- 32.10%
- Q3
- 16.03%
- Median
- 2.28%
- Q1
- -7.96%
- Min
- -26.84%
ALC’s Operating Profit Margin of 15.22% is around the midpoint for the Medical - Instruments & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
DOCS
39.94%
Medical - Healthcare Information Services Industry
- Max
- 39.94%
- Q3
- 11.27%
- Median
- 3.94%
- Q1
- -9.81%
- Min
- -29.30%
An Operating Profit Margin of 39.94% places DOCS in the upper quartile for the Medical - Healthcare Information Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | ALC | DOCS |
|---|---|---|
| Return on Equity (TTM) | 6.95% | 22.38% |
| Return on Assets (TTM) | 3.61% | 17.65% |
| Return on Invested Capital (TTM) | 4.39% | 17.37% |
| Net Profit Margin (TTM) | 11.27% | 39.13% |
| Operating Profit Margin (TTM) | 15.22% | 39.94% |
| Gross Profit Margin (TTM) | 55.55% | 90.20% |
Financial Strength
Current Ratio
ALC
2.70
Medical - Instruments & Supplies Industry
- Max
- 6.79
- Q3
- 4.57
- Median
- 2.64
- Q1
- 1.81
- Min
- 1.10
ALC’s Current Ratio of 2.70 aligns with the median group of the Medical - Instruments & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
DOCS
6.97
Medical - Healthcare Information Services Industry
- Max
- 5.37
- Q3
- 3.30
- Median
- 1.91
- Q1
- 1.37
- Min
- 0.54
DOCS’s Current Ratio of 6.97 is exceptionally high, placing it well outside the typical range for the Medical - Healthcare Information Services industry. This indicates a very strong liquidity position, though such a high ratio may also suggest that the company is not using its assets efficiently to generate profits.
Debt-to-Equity Ratio
ALC
0.24
Medical - Instruments & Supplies Industry
- Max
- 1.46
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.16
- Min
- 0.03
ALC’s Debt-to-Equity Ratio of 0.24 is typical for the Medical - Instruments & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
DOCS
0.01
Medical - Healthcare Information Services Industry
- Max
- 1.14
- Q3
- 0.65
- Median
- 0.16
- Q1
- 0.04
- Min
- 0.00
Falling into the lower quartile for the Medical - Healthcare Information Services industry, DOCS’s Debt-to-Equity Ratio of 0.01 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio
ALC
7.72
Medical - Instruments & Supplies Industry
- Max
- 25.04
- Q3
- 8.80
- Median
- 3.66
- Q1
- -3.85
- Min
- -11.93
ALC’s Interest Coverage Ratio of 7.72 is positioned comfortably within the norm for the Medical - Instruments & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
DOCS
--
Medical - Healthcare Information Services Industry
- Max
- 12.12
- Q3
- 3.11
- Median
- 1.20
- Q1
- -12.03
- Min
- -25.76
Interest Coverage Ratio data for DOCS is currently unavailable.
Financial Strength at a Glance
| Symbol | ALC | DOCS |
|---|---|---|
| Current Ratio (TTM) | 2.70 | 6.97 |
| Quick Ratio (TTM) | 1.66 | 6.97 |
| Debt-to-Equity Ratio (TTM) | 0.24 | 0.01 |
| Debt-to-Asset Ratio (TTM) | 0.17 | 0.01 |
| Net Debt-to-EBITDA Ratio (TTM) | 1.54 | -0.82 |
| Interest Coverage Ratio (TTM) | 7.72 | -- |
Growth
The following charts compare key year-over-year (YoY) growth metrics for ALC and DOCS. These metrics are based on the companies’ annual financial reports.
Revenue Growth
Earnings Per Share (EPS) Growth
Free Cash Flow Growth
Dividend
Dividend Yield
ALC
0.38%
Medical - Instruments & Supplies Industry
- Max
- 4.02%
- Q3
- 0.38%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 0.38%, ALC offers a more attractive income stream than most of its peers in the Medical - Instruments & Supplies industry, signaling a strong commitment to shareholder returns.
DOCS
0.00%
Medical - Healthcare Information Services Industry
- Max
- 7.19%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DOCS currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio
ALC
11.23%
Medical - Instruments & Supplies Industry
- Max
- 76.77%
- Q3
- 11.37%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ALC’s Dividend Payout Ratio of 11.23% is within the typical range for the Medical - Instruments & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
DOCS
0.00%
Medical - Healthcare Information Services Industry
- Max
- 130.89%
- Q3
- 2.61%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
DOCS has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | ALC | DOCS |
|---|---|---|
| Dividend Yield (TTM) | 0.38% | 0.00% |
| Dividend Payout Ratio (TTM) | 11.23% | 0.00% |
Valuation
Price-to-Earnings Ratio
ALC
38.80
Medical - Instruments & Supplies Industry
- Max
- 45.65
- Q3
- 44.10
- Median
- 35.47
- Q1
- 29.60
- Min
- 21.65
ALC’s P/E Ratio of 38.80 is within the middle range for the Medical - Instruments & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
DOCS
52.06
Medical - Healthcare Information Services Industry
- Max
- 114.57
- Q3
- 67.12
- Median
- 45.42
- Q1
- 28.19
- Min
- 6.48
DOCS’s P/E Ratio of 52.06 is within the middle range for the Medical - Healthcare Information Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Forward P/E to Growth Ratio
ALC
2.54
Medical - Instruments & Supplies Industry
- Max
- 5.80
- Q3
- 3.68
- Median
- 2.56
- Q1
- 1.87
- Min
- 0.22
ALC’s Forward PEG Ratio of 2.54 is within the middle range of its peers in the Medical - Instruments & Supplies industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.
DOCS
2.41
Medical - Healthcare Information Services Industry
- Max
- 6.35
- Q3
- 2.93
- Median
- 2.00
- Q1
- 0.55
- Min
- 0.03
DOCS’s Forward PEG Ratio of 2.41 is within the middle range of its peers in the Medical - Healthcare Information Services industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.
Price-to-Sales Ratio
ALC
4.37
Medical - Instruments & Supplies Industry
- Max
- 12.87
- Q3
- 6.95
- Median
- 3.45
- Q1
- 2.24
- Min
- 0.71
ALC’s P/S Ratio of 4.37 aligns with the market consensus for the Medical - Instruments & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
DOCS
20.31
Medical - Healthcare Information Services Industry
- Max
- 10.90
- Q3
- 5.95
- Median
- 2.46
- Q1
- 1.42
- Min
- 0.36
With a P/S Ratio of 20.31, DOCS trades at a valuation that eclipses even the highest in the Medical - Healthcare Information Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.
Price-to-Book Ratio
ALC
1.98
Medical - Instruments & Supplies Industry
- Max
- 9.60
- Q3
- 5.48
- Median
- 3.37
- Q1
- 1.95
- Min
- 0.65
ALC’s P/B Ratio of 1.98 is within the conventional range for the Medical - Instruments & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
DOCS
10.73
Medical - Healthcare Information Services Industry
- Max
- 12.91
- Q3
- 6.69
- Median
- 2.84
- Q1
- 1.88
- Min
- 1.03
The P/B Ratio is often not a primary valuation metric for the Medical - Healthcare Information Services industry.
Valuation at a Glance
| Symbol | ALC | DOCS |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 38.80 | 52.06 |
| Forward PEG Ratio (TTM) | 2.54 | 2.41 |
| Price-to-Sales Ratio (P/S, TTM) | 4.37 | 20.31 |
| Price-to-Book Ratio (P/B, TTM) | 1.98 | 10.73 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 25.24 | 43.20 |
| EV-to-EBITDA (TTM) | 19.18 | 47.31 |
| EV-to-Sales (TTM) | 4.75 | 19.97 |